1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. FENNEC PHARMACEUTICALS INC
Fennec Pharmaceuticals Inc XNAS: FENC

Fennec Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

about

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

Read More
8.87 0.00 (0.00%)
123.99% Gain from 52W Low
31,895
XNAS Volume

XNAS 29 Aug, 2025 4:01 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
19.2 / 100
Momentum Score
Technically Moderately Bullish
69.1 / 100
Analyst Price Target
14
1Yr Price target upside is 58%
5 analysts

16

S

4

W

3

O

1

T

SWOT Analysis

Fennec Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..